| 1.3 -0.04 (-2.99%) | 03-12 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 1.93 |
1-year : | 2.19 |
| Resists | First : | 1.65 |
Second : | 1.87 |
| Pivot price | 1.41 |
|||
| Supports | First : | 1.28 |
Second : | 1.07 |
| MAs | MA(5) : | 1.32 |
MA(20) : | 1.45 |
| MA(100) : | 2.02 |
MA(250) : | 2.91 |
|
| MACD | MACD : | -0.2 |
Signal : | -0.2  |
| %K %D | K(14,3) : | 8.3 |
D(3) : | 9.2 |
| RSI | RSI(14): 32.4 |
|||
| 52-week | High : | 7.94 | Low : | 1.28 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ VVOS ] has closed above bottom band by 17.9%. Bollinger Bands are 32.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 1.4 - 1.41 | 1.41 - 1.42 |
| Low: | 1.27 - 1.28 | 1.28 - 1.29 |
| Close: | 1.29 - 1.3 | 1.3 - 1.31 |
Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. Vivos Therapeutics also offers VivoScore Program, a screening and home sleep test in adults and children. The company markets and sells its Vivos System to licensed professionals, primarily general dentists in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2016 and is based in Highlands Ranch, Colorado.
Thu, 05 Feb 2026
VIVOS Therapeutics, Inc. ($VVOS) Signs 12-Part Media Series with New to The Street - Newswire.com
Tue, 20 Jan 2026
Vivos Therapeutics Signs Warrant Inducement Agreement With Institutional Investor - TradingView
Tue, 20 Jan 2026
Sleep apnea device maker Vivos raises $4.64M in repriced warrant deal - Stock Titan
Mon, 05 Jan 2026
Vivos Therapeutics (VVOS) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 10 (M) |
| Shares Float | 7 (M) |
| Held by Insiders | 23.4 (%) |
| Held by Institutions | 11 (%) |
| Shares Short | 465 (K) |
| Shares Short P.Month | 416 (K) |
| EPS | -1.77 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.31 |
| Profit Margin | -98.8 % |
| Operating Margin | -69.8 % |
| Return on Assets (ttm) | -49.8 % |
| Return on Equity (ttm) | -335.5 % |
| Qtrly Rev. Growth | 75.6 % |
| Gross Profit (p.s.) | 0.92 |
| Sales Per Share | 1.65 |
| EBITDA (p.s.) | -1.47 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -14 (M) |
| Levered Free Cash Flow | -9 (M) |
| PE Ratio | -0.74 |
| PEG Ratio | 0 |
| Price to Book value | 4.19 |
| Price to Sales | 0.78 |
| Price to Cash Flow | -0.95 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|